Loading...
Nexien BioPharma, Inc.
NXEN•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.01
$0.00(0.00%)
Nexien BioPharma, Inc. (NXEN) Financial Performance & Statements
Review Nexien BioPharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
44.92%
↑ 44.92%
Net Income Growth
33.93%
↑ 33.93%
Operating Cash Flow Growth
21.27%
↑ 21.27%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
9.52%
↑ 9.52%
ROIC
0.00%
↑ 0.00%
Nexien BioPharma, Inc. (NXEN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Nexien BioPharma, Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $24027.00 | $15710.00 | $64285.00 | $15947.00 |
| Operating Expenses | $24027.00 | $15710.00 | $64285.00 | $15947.00 |
| Total Costs & Expenses | $24027.00 | $15710.00 | $64285.00 | $15947.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $15445.00 | $16294.00 | $22229.00 | $37216.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $15947.00 |
| EBITDA | -$24027.00 | -$15710.00 | -$64285.00 | $0.00 |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | $0.00 | -$64285.00 | -$15949.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$39472.00 | -$32004.00 | -$22229.00 | -$37216.00 |
| Income Before Tax | -$39472.00 | -$32004.00 | -$86514.00 | -$53163.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$15946.00 |
| Net Income | -$39472.00 | -$32004.00 | -$86514.00 | -$53163.00 |
| Net Income Ratio | ||||
| EPS | -$557.79 | -$0.001 | -$0.001 | -$0.001 |
| Diluted EPS | -$557.79 | -$0.001 | -$0.001 | -$0.001 |
| Weighted Avg Shares Outstanding | $70.77M | $70.47M | $64.02M | $66.38M |
| Weighted Avg Shares Outstanding (Diluted) | $70.77M | $70.47M | $64.02M | $66.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan